Le Le Zhang
Gründer bei CUTIA THERAPEUTICS
Vermögen: - $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Le Le Zhang
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 14 | |
Shenyang Pharmaceutical University
13
| College/University | Other Consumer Services | 13 |
Cutia Therapeutics (Shanghai) Co., Ltd.
 Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Cutia Therapeutics, Cutia Therapeutics (Shanghai) Co., Ltd. develops therapeutics to treat severe facial acne vulgaris. The company is based in Shanghai, China. The Chinese company was founded in 2019. The CEO is Le Le Zhang.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Shanghai Institute of Pharmaceutical Industry
2
| College/University | Other Consumer Services | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Le Le Zhang
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Oxford | College/University | Doctorate Degree | |
| SHANGHAI PHARMACEUTICALS HOLDING CO., LTD | Pharmaceuticals: Major | Chief Investment Officer | |
| Xi'an Jiaotong University | College/University | Undergraduate Degree | |
| SINOCELLTECH GROUP LIMITED | Miscellaneous Commercial Services | Director/Board Member | |
| Shanghai Jiao Tong University | College/University | Doctorate Degree Graduate Degree | |
| Jilin University | College/University | Undergraduate Degree Graduate Degree | |
| The Hong Kong Polytechnic University | College/University | Undergraduate Degree | |
Shanghai University of Finance & Economics
 Shanghai University of Finance & Economics Other Consumer ServicesConsumer Services Shanghai University of Finance and Economics engages in the provision of educational services. It offers courses under the following school and departments: business, accountancy, finance, international business administration, economics, public economics and administration, humanities, law, information management and engineering, statistics, foreign languages, mathematics, international cultural exchange, professional and international education and continuing education. The company was founded in 1917 and is headquartered in Shanghai, China. | College/University | Masters Business Admin Undergraduate Degree | |
Qiming Venture Partners Ltd.
 Qiming Venture Partners Ltd. Investment ManagersFinance Qiming Venture Partners Ltd (Qiming Venture Partners) is a venture capital subsidiary of Qiming Caymen Ltd founded in 2006 by Gary Rieschel, Zi Ping Kuang and Ignition Partners LLC. The firm is headquartered in Shanghai, China. | Investment Managers | Private Equity Investor | |
| Cheung Kong Graduate School of Business | College/University | Masters Business Admin | |
| Southwest Jiaotong University | College/University | Undergraduate Degree Undergraduate Degree | |
Harvest Global Investments Ltd.
 Harvest Global Investments Ltd. Investment ManagersFinance Harvest Global Investments Ltd. (HGI) is the wholly-owned, Hong Kong-based investment management subsidiary of Harvest Fund Management Co., Ltd. (HFM), an asset management company headquartered in China. Founded in 2008, HGI provides discretionary portfolio management services to their clients, sometimes with the assistance of HFM, serving as the investment adviser to pooled investment vehicles sponsored by other financial firms. They also provide investment advisory services on behalf of sophisticated institutional investors to separately managed accounts. | Investment Managers | Corporate Officer/Principal | |
| China Pharmaceutical University | College/University | Undergraduate Degree Undergraduate Degree | |
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Pharmaceuticals: Major | Corporate Secretary | |
| Santen Pharmaceutical (China) Co. Ltd. | Chief Tech/Sci/R&D Officer | ||
| CBMG Holding AB | Director/Board Member | ||
| SINOMAB BIOSCIENCE LIMITED | Biotechnology | Corporate Secretary | |
| TOT BIOPHARM INTERNATIONAL COMPANY LIMITED | Pharmaceuticals: Major | General Counsel | |
| ADAGENE INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SINO BIOLOGICAL,INC. | Pharmaceuticals: Major | Director/Board Member | |
| BOILL HEALTHCARE HOLDINGS LIMITED | Real Estate Development | Corporate Secretary | |
| SINO GAS HOLDINGS GROUP LIMITED | Gas Distributors | Corporate Secretary | |
EPS International (China) Co. Ltd.
 EPS International (China) Co. Ltd. Data Processing ServicesTechnology Services Part of EPS Holdings, Inc., EPS International (China) Co. Ltd. is a Chinese company that provides clinical research services, computer software, and data management services for the healthcare industry. The company is based in Shanghai, China. | Data Processing Services | General Counsel | |
| CHINA ORAL INDUSTRY GROUP HOLDINGS LIMITED | Recreational Products | Corporate Secretary | |
Hisun Pfizer Pharmaceuticals Co., Ltd.
 Hisun Pfizer Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Hisun Pfizer Pharmaceuticals Co., Ltd. engages in the development, production, marketing, and sale of pharmaceutical products. It offers medicine in the form of tablets, hard capsules, and injection. The company was founded on September 6, 2012 and is headquartered in Hangzhou, China. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PUTIAN COMMUNICATION GROUP LIMITED | Electrical Products | Corporate Secretary | |
Beijing Shenogen Pharma Group Ltd.
 Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Pharmaceuticals: Major | Director/Board Member | |
Beijing Jiakesi New Drug Development Co. Ltd.
 Beijing Jiakesi New Drug Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Jiakesi New Drug Development Co. Ltd. develops and sells drugs. The company was founded by Yinxiang Wang on July 17, 2015 and is headquartered in Beijing, China. | Pharmaceuticals: Major | Director/Board Member | |
| SHANXI INSTALLATION GROUP CO., LTD. | Engineering & Construction | Corporate Secretary | |
Sinotau Pharmaceuticals Group
 Sinotau Pharmaceuticals Group Pharmaceuticals: MajorHealth Technology Sinotau Pharmaceuticals Group is a Chinese pharmaceutical company founded in 2005 that focuses on becoming an overall solution provider in the field of neurological degenerative lesions. The company is based in Beijing, China, and has subsidiaries in China. The company offers a range of products and services, including nuclear medicine, radioactive drug development, high-quality production, and clinical academic promotion. The company has a drug research and development technology platform and monoclonal antibody research and development drug technology platform, supplemented by generic drug research and development, production, and sales. The company also offers targeted drugs, precise diagnosis, and precision therapy drugs guided by research, development, and commercial molecular images. | Pharmaceuticals: Major | President | |
| CM HI-TECH CLEANROOM LIMITED | Building Products | Corporate Secretary | |
| OCUMENSION THERAPEUTICS | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Sironax Ltd.
 Sironax Ltd. Pharmaceuticals: MajorHealth Technology Sironax Ltd. is a clinical-stage biotechnology company located in Beijing, China. The Chinese company is dedicated to discovering and developing novel treatments for patients with age-related degenerative diseases. Sironax has built a diverse pipeline of multiple programs, focusing on key mechanisms underlying age-related degenerative diseases including regulated cell death, neuroprotective pathways, and neuroinflammation. Currently, Sironax is conducting early clinical studies with sir0365 and sir2446, in addition to ongoing preclinical research. | Pharmaceuticals: Major | Director/Board Member | |
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Biotechnology | Director/Board Member | |
| Jacobio Hk Pharmaceuticals Co. Ltd. | Director/Board Member | ||
| Asia Baokang Pharmaceutical Consulting Beijing Co. Ltd. | Corporate Officer/Principal | ||
| Suzhou Qiyuan Equity Investment Mgmt Partnership Enterprise LP | Corporate Officer/Principal | ||
Beijing Sinotau Pharmaceutical Technology Co., Ltd.
 Beijing Sinotau Pharmaceutical Technology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Sinotau Pharmaceuticals Group, Beijing Sinotau Pharmaceutical Technology Co., Ltd. is a company founded in 2005 that engages in research & development, manufacture and promotion of radiopharmaceuticals and biological antibody drugs. The company is based in Beijing, China. | Miscellaneous Commercial Services | President | |
Suzhou Cure Genetics Co., Ltd.
 Suzhou Cure Genetics Co., Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Cure Genetics Co., Ltd. is a biotechnology company based in Suzhou, China. The Chinese company specializes in developing gene and cell therapy for tumors and genetic diseases. | Pharmaceuticals: Major | Director/Board Member | |
| Suzhou Keyue Biotech Co. Ltd. | Director/Board Member | ||
| ABBISKO CAYMAN LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| Guangdong Xiantong Molecular Imaging Technology Co. Ltd. | Director/Board Member | ||
| The Hong Kong Chartered Governance Institute | Corporate Officer/Principal | ||
| VISION DEAL HK ACQUISITION CORP. | Financial Conglomerates | Corporate Secretary | |
| SEACON SHIPPING GROUP HOLDINGS LIMITED | Marine Shipping | Corporate Secretary | |
VISEN Pharmaceuticals
 VISEN Pharmaceuticals BiotechnologyHealth Technology VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Shanghai, China. | Biotechnology | Corporate Secretary | |
MicroPort Cardiac Rhythm Management International Ltd.
 MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Financial Conglomerates | Director/Board Member |
Statistik
International
| China | 33 |
| Hong Kong | 9 |
| Cayman Islands | 7 |
| Vereinigtes Königreich | 2 |
| Schweden | 2 |
Sektoral
| Health Technology | 17 |
| Consumer Services | 10 |
| Finance | 8 |
| Commercial Services | 3 |
| Producer Manufacturing | 3 |
Operativ
| Director/Board Member | 77 |
| Corporate Officer/Principal | 34 |
| Undergraduate Degree | 25 |
| Corporate Secretary | 23 |
| Graduate Degree | 15 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Lian Yong Chen | 24 |
| Sze Ting Chan | 24 |
| Yan Min Tang | 17 |
| Yun Xia Yang | 15 |
| Ju Bo Liu | 11 |
| Dong Mei Su | 11 |
| Ming Kit Chung | 9 |
| Xiao Huang | 8 |
| Qin Xie | 8 |
| Ru Li | 8 |
| Tak Yan Tao | 7 |
| Wei Cheng Zhou | 7 |
| Qi Zhu | 5 |
| Zhao Peng Hu | 4 |
| Dan Liu | 4 |
- Börse
- Insiders
- Le Le Zhang
- Unternehmensverbindungen